Stem Cell Innovations ICO logo
View web-site

Stem Cell Innovations ICO

Past ICO
Nov 21, 2018 – Jan 17, 2019

Stem Cell Innovations focuses on research and development in the field of stem cell science, with the dual purposes of furthering human longevity and expanding access to stem cell treatments through cutting-edge technology.

By investing in this ICO you agree to our Disclaimer

Stem Cell Innovations ratings

ICOrating.com Stem Cell Innovations icorating
Hype score Medium
Risk score NA
Investment rating NA
ICObench.com Stem Cell Innovations icobench 2.8 / 5
ICOmarks.com Stem Cell Innovations icomarks 8.8 / 10
TrackICO.io NA
ICOholder.com Stem Cell Innovations icoholder 0 / 5
Our rating
4.8
Claim admin rights for this ICO

Overview

Project industry Drugs & Healthcare
Product type App

Features

The Stem Cell Innovations (SCI) team claim that their solution will run on two blockchain platforms. The first platform will be built on Ethereum and will be used only for ERC20 tokens. The second custom blockchain will be developed by the SCI engineers specifically for the healthcare environment. Via the SCI app users will be able to buy cord blood services, purchase medical supplies, acquire synthetic stem cells, etc. The ERC20 SCIA tokens will be used to access and pay for the platform services.

ICO Details

ICO token supply: 240,000,000
Soft cap: 3,000,000USD (fiat)
Hard cap: 36,000,000 USD(fiat)

Legal

Country limitations: China, Cuba, Iran, Syria, United States, North Korea,
Registration country: Gibraltar

Token info

Ticker: SCIA
Type: Utility-token
Token price in USD: 1 SCIA = 0.15 USD
Accepted currencies: ETH BTC LTC USD EUR
Bonus program:
Pre-Sale Bonuses:
Day 1-7: 60% bonus
Day 8-14: 55% bonus
Day 15-21: 50% bonus
Day 22-28: 45% bonus
Day 29-42: 40% bonus
Main-Sale Bonuses:
Day 43-54: 30% bonus
Day 55-69: 25% bonus
Day 70-End: 15% bonus
Funds allocation:
22% - Marketing & Sales
18% - Infrastructure and Project Management
18% - Team and Advisors
15% - IT Development & R&D
11% - International Expansion and Partnership of Stem Labs
9% - Legal
5% - Reserve
2% - Lobbuing Stem Cell USFDA

Stem Cell Innovations Roadmap

1
2013

Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.

2
Q4 2017

Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.
Advanced research begins to determine market and development opportunities.

3
Q1 2018

Attended Token 2049 conference in Hong Kong.
Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).
Attended CBC conference in San Francisco, CA.

4
Q2 2018

Attended ICO20 Summit in Santa Monica, CA.
Integration of smart contract technology is established.
Company headquarters incorporated in Gibraltar, GB.
Strategic efforts toward development begins.
Interviews with potential medical participants take place.

5
Q3 2018

Whitelist is scheduled to go live.
Token Sale starts.

6
Q4 2018

Token Sale ends and min max caps are assessed.
Distribution of Tokens to participants through ERC20 will commence.

7
Q1 2019

SCI will begin final testing and reporting based on blockchain technology being used.
Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.
Demo testing for SCI Application v 1.0 will begin.

8
Q2 2019

Release of the SCI Application v1.1
Enrollment begins for doctors, patients, and stem cell laboratories in the United States

9
Q3 2019

Release of Market Surveillance strategy for further growth
Release SCI Application v2.0
Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.
Announcement of first SCI Lab location and franchise expansion plan.

10
Q4 2019

Announcement of clinical development and research strategy in the stem cell field.
Public announcement regarding SCI achievements to date.
First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.

11
Q1 2020

Stem Cell Lab Evaluation report per first year of operation and development.
Release SCI earnings and financials report.
Release results of SCI's stem cell research and development to date.

12
Q2 2020

Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.
Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.

13
Q3 2020

Begin second phase of SCI stem cell research and development.
Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.

14
Q4 2020

Expansion and acquisition of SCI stem cell labs and clinics in Europe.

15
Q1 2021

Release SCI earnings and financials report for second year operation and development.
Release public update on SCI stem cell research and development.
Stem Cell Lab Evaluation report for second year.

16
Q2 2021

Release SCI Application v4.0 including:
A new platform for medical students, universities, and hospitals to engage with the SCI Application.
Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.

Project team

Chief Executive Officer / Founder in Stem Cell Innovations - 1
Moe Galal
Chief Executive Officer / Founder
linkedin
Chief Operations Officer / Co-Founder in Stem Cell Innovations - 2
Ben Barel
Chief Operations Officer / Co-Founder
linkedin
Chief Technology Officer / Co-Founder in Stem Cell Innovations - 3
Ali Alrashidi
Chief Technology Officer / Co-Founder
linkedin
Chief of Staff / Co-Founder in Stem Cell Innovations - 4
Matt Galal
Chief of Staff / Co-Founder
linkedin
Operations Engineer / Co-Founder in Stem Cell Innovations - 5
Kobi Barel
Operations Engineer / Co-Founder
linkedin
Medical Director in Stem Cell Innovations - 6
John Glavinovich, M.D.
Medical Director
linkedin
Health Informatics Manager in Stem Cell Innovations - 7
Philip Glukhovsky, D.C.
Health Informatics Manager
linkedin
VP of Marketing in Stem Cell Innovations - 8
Roger Williams
VP of Marketing
linkedin
VP, PR & Corporate Communications in Stem Cell Innovations - 9
Liz Curlett
VP, PR & Corporate Communications
linkedin
Business Development in Stem Cell Innovations - 10
Candice Kouchache
Business Development
linkedin
VP of International Human Resources in Stem Cell Innovations - 11
Ahmed Elsantawi
VP of International Human Resources
linkedin
Web Designer in Stem Cell Innovations - 12
David Marmon
Web Designer
linkedin
Copywriter in Stem Cell Innovations - 13
Heather Deveaux
Copywriter
linkedin
Creative Writer in Stem Cell Innovations - 14
Everlecia Taylor
Creative Writer
linkedin
Administrative Manager in Stem Cell Innovations - 15
Marina Evglevskaya
Administrative Manager
linkedin
Product Manager in Stem Cell Innovations - 16
Rakel Apodaca
Product Manager
linkedin
Marketing in Stem Cell Innovations - 17
Michelle Chavon
Marketing
linkedin

Advisors

 in Stem Cell Innovations - 18
Boyan Josic
linkedin
 in Stem Cell Innovations - 19
Marc X. Ellul
linkedin
 in Stem Cell Innovations - 20
Roger Shortz, M.D.
linkedin
 in Stem Cell Innovations - 21
Greg Maddex, D.O
linkedin

Social media

Web-site Reddit Medium YouTube Telegram Instagram btctalk LinkedIn Twitter Facebook

User rating:

5/5 ( 1 )

How-To get a verified ICO status

To pass the verification you need to place a our logo on the main page of your ICO's website and make an announcement of the listing in your social network accounts. Send us the email in reply with confirmation of the link placement.

Horizontal
Square
Light
Dark
Height: 50 px
Widht: 160 px

Leave a Reply

Your email address will not be published. Required fields are marked *

Top-Rated ICO's

9.1
Verification off icon
ETHEAL (HEAL)
ETHEAL (HEAL)
ETHEAL is an Operating System of Healthcare Industry.
Start ICO TBA
End ICO TBA
Received Pending
Goal $ 30,510,200 (fiat)
9.1
Bounty Program iconVerification off icon
Eternal Trusts (ETT)
Eternal Trusts (ETT)
Eternal Trusts is a blockchain platform that enables autonomous, deferred purchases of emerging biomedical and other services unavailable at the current moment.
Start ICO TBA
End ICO TBA
Received $ 6,193,371 34%
Goal $ 18,000,000 (fiat)
9.1
Verification off icon
FarmaTrust (FTT)
FarmaTrust (FTT)
FarmaTrust is a web-based, peer to peer platform designed to keep an immutable record of every legitimate drug ever produced.
Start ICO TBA
End ICO TBA
Received Pending
Goal $ 20,250,000
9
Bounty Program iconVerification off icon
Jibbit (JIB)
Jibbit (JIB)
Jibbit creates an ecosystem network to connect the worldwide cannabis community with the crypto world (200m +). A world to make the cannabis market completely i ...
Start ICO TBA
End ICO TBA
Received Pending
Goal Not Set